FDAnews
www.fdanews.com/articles/72987-bioinvent-and-cambridge-antibody-technology-sign-licensing-agreement

BioInvent and Cambridge Antibody Technology Sign Licensing Agreement

June 3, 2005

BioInvent International AB announced that it has entered into a license agreement with Cambridge Antibody Technology. Under the agreement BioInvent and its partners receive rights to use CAT's antibody phage display patent estate to develop products from BioInvent's n-CoDeRÒ antibody libraries. As part of the agreement BioInvent has agreed to withdraw its opposition to CAT's patents filed at the European Patent Office in Munich.

()a href="http://www.bioportfolio.com/news/bioinvent_2.htm" target="_blank">BioPortfolio